Outlook Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Outlook Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Outlook Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Outlook Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Outlook Therapeutics Inc (Outlook Therapeutics) is a biopharmaceutical company focused on developing and commercializing therapies for ophthalmic indications. The company develops ONS-5010, a monoclonal antibody designed for the treatment of retinal diseases. ONS-5010 (LYTENAVA) is an investigational ophthalmic formulation of bevacizumab. The product treats wet age-related macular degeneration, diabetic macular edema, and branch retinal vein occlusion. It also collaborates with biotechnology and pharmaceutical companies to develop its products. The company operates across the US. Outlook Therapeutics is headquartered in Cranbury, New Jersey, the US.
Headquarters
United States of America
Address
111 S. Wood Avenue, Unit #100, Iselin, New Jersey, 08830
Website
outlooktherapeutics.com
Telephone
1 609 6193990
No of Employees
17
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
OTLK (NASD)
Revenue (2024)
$1.4M
EPS
XYZ
Net Income (2024)
XYZ
17.2%
(2024 vs 2023)
Market Cap*
$187.0M
Net Profit Margin (2024)
XYZ
0.0%
(2024 vs 2023)
* As of and is in US$
Outlook Therapeutics Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pipeline | Lytenava |
| ONS-5010 Lytenava |
Competitor Comparison
| Key Parameters | Outlook Therapeutics Inc | MeiraGTx Holdings Plc | Coherus Oncology Inc | EyePoint Inc | Hyperion DeFi Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Iselin | New York City | Redwood City | Watertown | New York City |
| State/Province | New Jersey | New York | California | Massachusetts | New York |
| No. of Employees | 17 | 403 | 145 | 214 | 9 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Faisal G. Sukhtian | Chairman | Executive Board | 2025 | 39 |
| Lawrence A. Kenyon | Chief Executive Officer - Interim; Chief Financial Officer; Director | Executive Board | 2015 | 58 |
| Jeff Evanson | Chief Commercial Officer | Senior Management | 2018 | 54 |
| Laura Cantrell | Vice President - Corporate Strategy and Business Development | Senior Management | 2026 | - |
| Randy Thurman | Director | Non Executive Board | 2018 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer